Literature DB >> 8792035

Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population.

M B Russell1, B K Rasmussen, K Fenger, J Olesen.   

Abstract

The clinical characteristics of migraine without aura (MO) and migraine with aura (MA) were compared in 484 migraineurs from the general population. We used the criteria of the International Headache Society. The lifetime prevalence of MO was 14.7% with a M:F ratio of 1:2.2; that of MA was 7.9% with a M:F ratio of 1:1.5. The female preponderance was significant in both MO and MA. The female preponderance was present in all age groups in MA, but was first apparent after menarche in MO, suggesting that female hormones are an initiating factor in MO, but not likely so in MA. The age at onset of MO followed a normal distribution, whereas the age at onset of MA was bimodally distributed, which could be explained by a composition of two normal distributions. The estimated separation between the two groups of MA was at age 26 years among the females and age 31 years among the males. The observed number of persons with co-occurrence of MO and MA was not significantly different from the expected number. The specificity and importance of premonitory symptoms are questioned, but prospective studies are needed. Bright light was a precipitating factor in MA, but not in MO. Menstruation was a precipitating factor in MO, but not likely in MA. Both MO and MA improved during pregnancy. The clinical differences indicate that MO and MA are distinct entities.

Entities:  

Mesh:

Year:  1996        PMID: 8792035     DOI: 10.1046/j.1468-2982.1996.1604239.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  72 in total

1.  Effects of stratification in the analysis of affected-sib-pair data: benefits and costs.

Authors:  S M Leal; J Ott
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

2.  Arctic environment triggers migraine attacks.

Authors:  Hallvard Lilleng; Svein Ivar Bekkelund
Journal:  Can Fam Physician       Date:  2010-06       Impact factor: 3.275

3.  Sensitivity and specificity of the new international diagnostic criteria for migraine with aura.

Authors:  M K Eriksen; L L Thomsen; J Olesen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

4.  [Alimentary trigger factors that provoke migraine and tension-type headache].

Authors:  J Holzhammer; C Wöber
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

Review 5.  Multisensory integration in migraine.

Authors:  Todd J Schwedt
Journal:  Curr Opin Neurol       Date:  2013-06       Impact factor: 5.710

6.  Co-occurrence of major depression or suicide attempt with migraine with aura and risk for unprovoked seizure.

Authors:  Dale C Hesdorffer; Pétur Lúdvígsson; W Allen Hauser; Elías Olafsson; Olafur Kjartansson
Journal:  Epilepsy Res       Date:  2007-06-15       Impact factor: 3.045

7.  Chromosome 19p13 loci in Finnish migraine with aura families.

Authors:  Mari A Kaunisto; Päivi J Tikka; Mikko Kallela; Suzanne M Leal; Jeanette C Papp; Arja Korhonen; Eija Hämäläinen; Hanna Harno; Hannele Havanka; Markku Nissilä; Erkki Säkö; Matti Ilmavirta; Jaakko Kaprio; Markus Färkkilä; Roel A Ophoff; Aarno Palotie; Maija Wessman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-01-05       Impact factor: 3.568

Review 8.  Genetics of menstrual migraine: the epidemiological evidence.

Authors:  Michael Bjørn Russell
Journal:  Curr Pain Headache Rep       Date:  2010-10

9.  Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study.

Authors:  Han Le; Peer Tfelt-Hansen; Axel Skytthe; Kirsten Ohm Kyvik; Jes Olesen
Journal:  J Headache Pain       Date:  2011-03-10       Impact factor: 7.277

10.  Hereditary patterns of Belgrade university female students with migraine and nonmigraine primary headache.

Authors:  Hristina D Vlajinac; Eleonora D Dzoljic; Sandra B Sipetic; Vlada S Kostic
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.